510(k) K160197
K160197 is an FDA 510(k) premarket notification submitted by Haemonetics Corporation for the device "Haemonetics Cell Saver Elite Autotransfusion System". The FDA issued a decision of Substantially Equivalent on May 24, 2016. The device falls under product code CAC (Apparatus, Autotransfusion), a Class II device regulated under 21 CFR 868.5830. Haemonetics Corporation has at least 6 other 510(k) clearances on record.
Clearance Details
- Decision
- SESE (Substantially Equivalent)
- Decision Date
- May 24, 2016
- Date Received
- January 27, 2016
- Clearance Type
- Traditional
- Expedited Review
- No
- Third Party Review
- No
Device Classification
- Device Name
- Apparatus, Autotransfusion
- Device Class
- Class II
- Regulation Number
- 868.5830
- Review Panel
- CV
- Submission Type